CNST Stock Ownership Activity

CONSTELLATION PHARMACEUTICAL 13F holders

No value investing guru has made any change to the CONSTELLATION PHARMACEUTICAL (CNST) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying CNST now?

According to the latest SEC filing(s) CONSTELLATION PHARMACEUTICAL (CNST) has not been purchased by any super investor.

To see more about who is investing in CONSTELLATION PHARMACEUTICAL (CNST), please go to the CNST ownership page.

2021 Q2 (1 result)
Ravenel Boykin Curry IV
-100.00%
-8,639
-0.00%
0.00%
Current price: $33.99 45.37% Reported price*: $23.38
2020 Q4 (1 result)
Ravenel Boykin Curry IV
buy
+8,639
+0.00%
0.00%
Current price: $33.99 17.93% Reported price*: $28.82
2020 Q3 (1 result)
Ravenel Boykin Curry IV
-100.00%
-8,639
-0.00%
0.00%
Current price: $33.99 12.94% Reported price*: $30.10
2019 Q4 (1 result)
Ravenel Boykin Curry IV
buy
+8,639
+0.00%
0.00%
Current price: $33.99 27.85% Reported price*: $47.11
4 of 4

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.